ANI Pharmaceuticals | ANIP - Net Income


ANI Pharmaceuticals reported $26.27M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
ANI Pharmaceuticals USD 26.27M 18.13M Sep/2025
Aurora Cannabis CAD -51.47M 36.26M Sep/2025
Canopy Growth CAD -1.64M 39.89M Sep/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Novartis USD 3.93B 113M Sep/2025
Perrigo USD 7.5M 15.9M Sep/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025